Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

1995

Zangari M, Kaplan KL, Glanville RW, Rand JH. Reduced thrombogenicity of type VI collagen as compared to type I collagen. Thromb Res. 1995;79(5-6):429-36.

Columbyova L, Loda M, Scadden DT. Thrombopoietin receptor expression in human cancer cell lines and primary tissues. Cancer Res. 1995;55(16):3509-12.

Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood. 1995;85(5):1396-403.

Zhang X, Blenis J, Li HC, Schindler C, Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science. 1995;267(5206):1990-4.

Matolcsy A, Chadburn A, Knowles DM. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am J Pathol. 1995;147(1):207-16.

McCaffrey TA, Consigli S, Du B, Falcone DJ, Sanborn TA, Spokojny AM, et al. Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. J Clin Invest. 1995;96(6):2667-75.

King R, Crowson AN, Murray E, Magro CM. Acral purpuric papulonodular lesions as a manifestation of Behçet's disease. Int J Dermatol. 1995;34(3):190-2.

Lin J, Qin L, Chavin KD, Ding Y, Punch JD, Yang Q, et al. CD3 and CD2 ligation alters CD49d epitope expression. Pathobiology. 1995;63(3):119-32.

Cagnoni PJ, Lenzi R, Wisch N, Seremetis S, Rand JH. Spurious fibrinogen levels secondary to pyroglobulinemia in Waldenström's macroglobulinemia. Am J Hematol. 1995;48(2):126-7.

Municio MM, Lozano J, Sanchez P, Moscat J, Diaz-Meco MT. Identification of heterogeneous ribonucleoprotein A1 as a novel substrate for protein kinase C zeta. J Biol Chem. 1995;270(26):15884-91.